NCT07266844 is a NA clinical trial of CAPSULaser in Intumescent Cataract, sponsored by Zagazig University.

Who is sponsoring NCT07266844?

NCT07266844 is sponsored by Zagazig University.

What drugs are being tested in NCT07266844?

Interventions in NCT07266844: CAPSULaser, capsulotomy.

What condition does NCT07266844 study?

NCT07266844 studies Intumescent Cataract.

Is NCT07266844 still recruiting?

NCT07266844 is currently completed. Last updated 5 December 2025.

Last reviewed 2025-12-05 · How we verify

NCT07266844

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CAPSULaser in Cases of Intumescent Cataract

Completed NA Last updated 5 December 2025

What this trial tests

NA trial testing CAPSULaser in Intumescent Cataract in 24 participants. Completed in 6 November 2025.

Timeline

8 July 2025

Primary endpoint
6 November 2025

6 November 2025

Quick facts

Lead sponsor	Zagazig University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	24
Start date	8 July 2025
Primary completion	6 November 2025
Estimated completion	6 November 2025
Sites	1 location across Saudi Arabia

Drugs / interventions tested

CAPSULaser
capsulotomy

Conditions studied

Intumescent Cataract — all drugs for Intumescent Cataract →

Sponsor

Zagazig University

Who can join

Eligibility, any sex, with Intumescent Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

evaluating the use of selective laser in doing capsulotomy in intumescent cataract

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07266844 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 5 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07266844.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing